Advertisement
UK markets close in 4 hours 34 minutes

  • FTSE 100

    8,082.89
    +38.08 (+0.47%)
     

  • FTSE 250

    19,797.30
    -2.42 (-0.01%)
     

  • AIM

    754.98
    +0.11 (+0.01%)
     

  • GBP/EUR

    1.1629
    +0.0001 (+0.01%)
     

  • GBP/USD

    1.2435
    -0.0017 (-0.14%)
     

  • Bitcoin GBP

    53,411.07
    +86.17 (+0.16%)
     

  • CMC Crypto 200

    1,433.34
    +9.24 (+0.65%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.82
    -0.54 (-0.65%)
     

  • GOLD FUTURES

    2,328.20
    -13.90 (-0.59%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,184.40
    +46.75 (+0.26%)
     

  • CAC 40

    8,133.13
    +27.35 (+0.34%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Smith & Nephew 2015 trading profit beats expectations

Reuters - UK Focus

LONDON, Feb 4 (Reuters) - Smith & Nephew (LSE: SN.L - news) , Europe's largest maker of artificial hips and knees, reported trading profit slightly ahead of consensus helped by strong demand for sports medicine in the fourth quarter, giving it confidence on growing revenues in 2016.

The company posted trading profit of $1.099 billion for 2015, ahead of a forecast of $1.079 billion from a company-compiled consensus of 17 analysts.

For 2016, Smith & Nephew said it expected underlying revenue growth to continue given the company's exposure to cutting-edge surgical technology.

Smith & Nephew said on Monday that its Chief Executive Olivier Bohuon has been diagnosed with a highly treatable form of cancer and that he would remain in his role during his treatment period.

(Reporting by Sarah Young, Editing by Paul Sandle)